Skip to Main Content
It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.

COVID-19 Intelligence Report: Pulmonary

May 11, 2020

Title: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19

Publisher: NEJM

Publication Date: 07 May 2020


Key Takeaways: As you saw in last week’s Intelligence Report, there has been a debate over the association of ACE inhibitors and increased risk of developing COVID or having a more severe disease course. This large observational study does not support this theory and supports the safety of using ACE inhibitors in COVID patients.

The Himmelfarb Health Sciences Library
Questions? Ask us.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

The George Washington University